Johan Arild Aarli

Johan Arild Aarli's AcademicInfluence.com Rankings

Johan Arild Aarli

Philosophy

#9935

World Rank

#13567

Historical Rank

Logic

#6888

World Rank

#8446

Historical Rank

philosophy Degrees

Johan Arild Aarli

Biology

#13664

World Rank

#17219

Historical Rank

Neuroscience

#2386

World Rank

#2451

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Johan Arild Aarli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Johan Arild Aarli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The epidemiology of Parkinson's disease in the county of Rogaland, Norway (1995) (197)
Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin (1990) (179)
Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. (2005) (148)
Late-onset myasthenia gravis: a changing scene. (1999) (130)
Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma (1992) (130)
Titin antibodies in myasthenia gravis (1993) (120)
Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy (1989) (119)
Muscle autoantibodies in subgroups of myasthenia gravis patients (2000) (117)
Myasthenia Gravis in the Elderly (2008) (113)
Epilepsy and the immune system. (2000) (108)
Binding of normal human IgG to myelin sheaths, glia and neurons. (1975) (103)
Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. (1983) (103)
Myasthenia gravis: clinical, immunological, and therapeutic advances (2005) (102)
Early prognostic factors for disability in multiple sclerosis, a European multicenter study (1992) (102)
The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. (2000) (94)
Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. (1994) (91)
Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. (2000) (90)
Paraneoplastic myasthenia gravis: Detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor (1997) (88)
Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. (1995) (85)
Immunological aspects of epilepsy (1993) (82)
Post‐polio syndrome patients treated with intravenous immunoglobulin: a double‐blinded randomized controlled pilot study (2007) (81)
Myasthenia Gravis: A Review of Available Treatment Approaches (2011) (79)
Role of cytokines in neurological disorders. (2003) (79)
Heart disease in myasthenia gravis (1984) (75)
The non-linear relationship between nerve conduction velocity and skin temperature. (1989) (73)
Western Norway, a high‐risk area for multiple sclerosis (1984) (71)
Guillain‐Barré syndrome: Demonstration of antibodies to peripheral nerve tissue (1978) (71)
Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features (2007) (70)
Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway (1991) (67)
Effect of Antiepileptic Drugs on Serum and Salivary IgA (1975) (67)
Multiple sclerosis – more than one disease? (1985) (67)
Drug-induced IgA deficiency in epileptic patients. (1976) (66)
Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. (1988) (64)
Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules (2002) (62)
Prognostic factors and survival in amyotrophic lateral sclerosis. (1994) (62)
Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination (1981) (58)
Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients (1985) (56)
Neurological long term consequences of deep diving. (1991) (56)
Lifestyle and late effects after poliomyelitis. A risk factor study of two populations (2004) (54)
[The brain and the immune system]. (1995) (54)
Myasthenia Gravis in Individuals over 40 (2003) (53)
Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations. (1991) (52)
Disease severity and outcome in thymoma myasthenia gravis: a long‐term observation study (2003) (51)
Thymomas express epitopes shared by the ryanodine receptor (1995) (51)
The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo (2005) (51)
WHO/WFN Survey of neurological services: A worldwide perspective (2006) (50)
Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern. (1991) (50)
Titin and ryanodine receptor antibodies in myasthenia gravis (2006) (47)
Ryanodine receptor antibodies in myasthenia gravis: Epitope mapping and effect on calcium release in vitro (2003) (47)
Phenytoin‐Induced Depression of Salivary IgA and Gingival Hyperplasia (1976) (46)
CHANGES IN SERUM IMMUNOGLOBULIN LEVELS DURING PHENYTOIN TREATMENT of EPILEPSY (1976) (46)
The clinical significance of spinal cord injuries in patients older than 60 years of age (2005) (42)
Guillain‐Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway (1996) (42)
Influence of occupational diving upon the nervous system: an epidemiological study. (1990) (42)
Immunological Aspects of Epilepsy (1980) (41)
TNFA and TNFB polymorphisms in myasthenia gravis. (1999) (40)
Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis. (2001) (40)
EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis (1999) (40)
Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum (1992) (40)
The immune system and the nervous system (2004) (37)
Long term outcome after poliomyelitis in different health and social conditions (2003) (36)
Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis A study of IgG subclasses and clinical correlations (2000) (35)
Rapsyn Antibodies in Myasthenia Gravis a (1998) (34)
Electroencephalography, evoked potentials and MRI brain scans in saturation divers. An epidemiological study. (1991) (34)
Glioblastoma associated with multiple sclerosis: coincidence or induction? (1989) (31)
Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. (1982) (30)
Thymectomy and anti‐muscle autoantibodies in late‐onset myasthenia gravis (2002) (30)
Pathogenesis of Myositis and Myasthenia Associated with Titin and Ryanodine Receptor Antibodies (2003) (29)
Neurology in sub-Saharan Africa (2007) (28)
Subclavian steal phenomenon Clinical and hemodynamic aspects (1994) (28)
Myasthenia gravis (1984) (28)
Myasthenia gravis. Antibodies to an acid-soluble antigen in striated muscle. (1972) (28)
Fcγ Receptor IIIA Polymorphism as a Risk Factor for Acute Poliomyelitis (2002) (27)
Late onset myasthenia gravis (1997) (27)
Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes (1998) (26)
Neuroborreliosis with Vasculitis Causing Stroke-Like Manifestations (2004) (26)
Inflammatory myopathy in myasthenia gravis. (1998) (25)
Organic solvents and multiple sclerosis: a case‐control study (1993) (25)
Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis. (1994) (25)
Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]‐ryanodine to sacroplasmic reticulum (1998) (24)
Arthritis in myasthenia gravis. (1975) (24)
Respiratory disease and nasal immunoglobulin concentrations in phenytoin‐treated epileptic patients (1981) (24)
HLA antigens in epileptic patients with drug-induced immunodeficiency. (1982) (24)
Polio survivors – well educated and hard working (2001) (22)
Serum concentrations of immunoglobulins in patients with epilepsy treated with carbamazepine (1980) (22)
Cerebral schistosomiasis presenting as a brain tumor. (1984) (22)
Cauda equina lesions in ankylosing spondylitis. (1977) (21)
Titin transcripts in thymomas. (1997) (21)
Central nervous dysfunction associated with deep‐sea diving (1985) (21)
Heart muscle antibodies in myasthenia gravis. (1991) (20)
Left ventricular function in myasthenia gravis. (1992) (20)
Symptomatic hemidystonia of delayed onset. Magnetic resonance demonstration of pathology in the putamen and the caudate nucleus (1989) (20)
Thymectomy and Antimuscle Antibodies in Nonthymomatous Myasthenia Gravis (2003) (20)
Nervous complications of measles. Clinical manifestations and prognosis. (1974) (20)
Fcgamma receptor IIIA polymorphism as a risk factor for acute poliomyelitis. (2002) (19)
IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. (1993) (19)
Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders. (1992) (19)
The histomorphology of the thymus in late onset, non‐thymoma myasthenia gravis (1998) (19)
Receptors for gammaglobulin in the central and peripheral nervous system. (1994) (19)
The reversibility of phenytoin-induced IgA deficiency (2004) (18)
Thymectomy for myasthenia gravis: evaluation requires controlled prospective studies. (2003) (18)
Myasthenia gravis antibodies to skeletal muscle cell surface antigens (1983) (18)
Neurological effects of deep diving (2011) (18)
Immunoglobulin allotypes in myasthenia gravis patients with a thymoma. (1990) (18)
Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. (1979) (18)
SEROLOGICAL DETECTION OF THYMOMA IN MYASTHENIA GRAVIS (1982) (17)
Autoimmunity against the ryanodine receptor in myasthenia gravis. (2001) (17)
IgG subclass distribution of myasthenia gravis thymoma‐associated antiskeletal muscle antibodies (1984) (16)
Thymectomy in Nonthymoma Early-Onset Myasthenia gravis in Correlation with Disease Severity and Muscle Autoantibodies (2003) (16)
Three Forms of Immune Myasthenia (2003) (15)
Herzmyasthenie: myasthenia of the heart. (2009) (15)
Plasma exchange in myasthenia gravis: effect on anti‐AChR antibodies and other autoantibodies (1986) (15)
Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis (1985) (15)
Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. (1989) (15)
Plasma exchange in myasthenia gravis: clinical effect (1985) (15)
Antiglobulin consumption test with sera from patients with myasthenia gravis. (1970) (14)
Localization and properties of an acid-soluble muscle antigen reacting with antibodies in myasthenia gravis sera. (2009) (14)
International Issues: Educational programs of the World Federation of Neurology (2009) (14)
GM1 antibodies in post-polio syndrome and previous paralytic polio (2003) (14)
Polymyositis with acute myolysis in a patient with rheumatoid arthritis treated with penicillamine and ampicillin. (1980) (14)
Myasthenia gravis: cross-striational fluorescence of muscle fibers mediated by Fc fragments. (1972) (14)
Titin, thymoma, and myasthenia gravis. (2001) (13)
Non-receptor striated muscle antibodies in sera from patients with myasthenia gravis. (1988) (13)
Complement factors and acute phase reactants in the Guillain-Barré syndrome. (1982) (13)
Binding of gamma-globulin fragments to muscle tissue. (1970) (12)
Respiratory disease in patients with epilepsy on single-drug therapy with carbamazepine or phenobarbital. (1982) (12)
Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin (1997) (12)
IMMUNOGLOBULIN CONCENTRATIONS IN FIRST‐DEGREE RELATIVES OF EPILEPTIC PATIENTS WITH DRUG‐INDUCED IgA DEFICIENCY (1977) (12)
Cystic Dilation of Virchow-Robin Spaces in the Midbrain (2002) (11)
Immediate neurological effects of diving to a depth of 360 metres (1989) (11)
EFFECT OF CLONAZEPAM (Ro 5‐4023) ON EPILEPTIC SEIZURES (1973) (11)
OCULOPHARYNGEAL MUSCULAR DYSTROPHY (1969) (11)
[Myasthenia gravis and thymoma]. (1990) (11)
Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies (1983) (11)
Evans blue as counterstain in the demonstration of muscle antibodies by immunofluorescence in myasthenia gravis (1974) (11)
Non-Metastatic Neurological Manifestations of Malignant Disease (1980) (11)
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis (2006) (10)
[Intravenous immunoglobulin in postpolio syndrome]. (2004) (10)
Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. (1997) (10)
Preoperative preparation of patients with myasthenia gravis forestalls postoperative respiratory complications after thymectomy. (2003) (10)
Detection of viral sequences in archival spinal cords from fatal cases of poliomyelitis in 1951-1952. (2003) (9)
Immunological aspects of neurological diseases. (1980) (9)
Thymic lymphoepitheliomas and skeletal muscle expressing common antigen(s) (1986) (9)
Immunoglobulins in epilepsy (2004) (9)
Stroke and neurology: a plea from the WFN (2003) (9)
The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients with Guillain-Barré syndrome (2004) (8)
The cerebrospinal fluid in myasthenia gravis (1985) (8)
Dopaminergic agonist Ro 8–4650 in Parkinson's disease (1978) (8)
Phenytoin-induced depression of salivary IgA. (1976) (8)
Long-term follow-up of patients with nonparalytic poliomyelitis. (2002) (8)
Neurology and psychiatry: “Oh, East is East and West is West …” (2005) (7)
The Ultrastructural Localization of Antigens for Skeletal Muscle Antibodies in Myasthenia Gravis (1987) (7)
Analysis of neurologic symptoms in deep diving: implications for selection of divers. (1990) (7)
Differential neuropsychological effects of diving to 350 meters. (1987) (7)
Recovery from global amnesia during plasma exchange in myasthenia gravis: report of a case (1989) (7)
Neurological manifestations in hyperlipidemia (1968) (7)
Rasmussen's encephalitis: a challenge to neuroimmunology. (2000) (7)
Effect of phenytoin on immunoglobulin concentrations in nasal secretions. (2009) (6)
Immunoglobulin concentrations in patients with a history of febrile convulsions prior to the development of epilepsy. (1981) (6)
Something in the Blood? A History of the Autoimmune Hypothesis regarding Myasthenia Gravis (2007) (5)
Singing Improves Word Production in Patients with Aphasia (2010) (5)
[Poliomyelitis--not an extinct disease. Outbreak of poliomyelitis in Vestlandet 1950-54]. (1997) (5)
Antibodies Against Nicotinic Acetylcholine Receptor and Skeletal Muscle in Human and Experimental Myasthenia Gravis (1975) (5)
Activation of blood platelets in workers exposed to organic solvents. (1992) (5)
Clinical Immunology of Thymic Tumors in Patients with Myasthenia Gravis (1997) (5)
Lymphocyte Subpopulations and IgG Concentrations in Cerebrospinal Fluid and Blood from Patients with Myasthenia Gravis (1980) (5)
[Patients with traumatic spinal cord injuries at the department of neurology, Haukeland Hospital 1952-99]. (2001) (4)
The History of the World Federation of Neurology: The First 50 Years (2014) (4)
ADENYLATE KINASE IN NEUROLOGICAL DISEASES (1979) (4)
[Plasma exchange in neurological diseases]. (1984) (4)
Skeletal muscle antibodies in thymoma patients without myasthenia gravis (1984) (4)
Antibodies Against Nicotinic Acetylcholine Receptor and Skeletal Muscle in Human and Experimental Myasthenia Gravis (1975) (4)
Myasthenia Gravis‐associated Ryanodine Receptor Antibodies Inhibit Binding of Ryanodine to Sarcoplasmic Reticulum (1998) (3)
MYASTHENIA GRAVIS: RESULTS OF SEROLOGICAL INVESTIGATIONS COMPARED WITH CLINICAL DATA (1971) (3)
Neurological perspectives on person-centered medicine (2010) (3)
Demonstration of antibodies to muscle by absorption of rheumatoid factor. (2009) (3)
Non-receptor muscle antibodies in myasthenia gravis are of IgG1 and IgG4 subclasses. (1992) (3)
Alpha-fetoprotein concentrations in sera from epileptic patients with immunodeficiency. (1982) (3)
Titin Transcripts in Thymomas (1998) (3)
Nerve conduction velocity in man during deep diving to 360 msw. (1989) (3)
Accessory Molecule Expression in Human Thymomas and Thymus (1997) (3)
Fc binding of IgG to skeletal muscle tissue. (1974) (2)
Tryggve Andersen: Epileptic Hallucinations in the 1890s, Fact or Fiction? (1995) (2)
PLASMAPHERESIS IN MYASTHENIA GRAVIS. CLINICAL RESULTS AND CHANGES IN SERUM PROTEINS (1982) (2)
Immunoglobulin G in serum and cerebrospinal fluid from epileptic patients treated with phenytoin. (1979) (2)
[5-year experience with a clinic for amyotrophic lateral sclerosis]. (1997) (2)
When is a global health program global? (2013) (2)
Myasthenia gravis patients with a thymoma have antibodies against a sarcoplasmic reticulum protein (1991) (2)
[Treatment of myasthenia gravis]. (1982) (2)
Interaction of Fcγ in Coombs’ Test with Tanned Red Cells (1973) (2)
Specificity of muscle antibodies in sera from patients with myasthenia gravis and from immunized rabbits (1974) (2)
[Thymectomy and muscle antibodies in myasthenia gravis]. (2004) (2)
The Neuropsychiatric Manifestations of Hashimoto's Disease: An Unrecognized Syndrome (1987) (1)
[Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis]. (1997) (1)
Immunoglobulin allotypes in myasthenia gravis (MG) patients with thymoma and non-receptor antibodies (1989) (1)
[Postviral fatigue syndrome]. (1995) (1)
Er trombolytisk behandling effektivt ved hjerneslag (2000) (1)
The World Federation of Neurology and the World Health Organization (2014) (1)
Detection of muscle antibodies in myastenia gravis sera. (1972) (1)
Neurology before the World Federation of Neurology (2014) (1)
[Mental retardation and epilepsy]. (1990) (1)
Heart disease in myasthenia gravis. (1984) (1)
Chapter 41: the history of neurology in Scandinavia. (2010) (1)
[Skeletons in the cupboard--treatment of Arne Torkildsen]. (2003) (1)
Thymomas Express Ryanodine Receptor Epitopes (1997) (1)
Global Perspectives (2011) (1)
The diagnosis of thymoma in myasthenia gravis (1983) (1)
Antibodies against sarcoplasmic reticulum in serum from patients with myasthenia gravis (1989) (1)
[Myasthenia gravis with myocarditis and sudden death]. (1987) (1)
Validity and reliability of the German language SF-36 health survey in patients with amyotrophic lateral sclerosis (2002) (1)
[abstract] NERVOUS SYSTEM INVOLVEMENT FROM OCCUPATIONAL DIVING. AN EPIDEMIOLOGICAL STUDY. (1990) (1)
[Arne Thorkildsen and Thorkildsen's surgery]. (2000) (1)
The wind of change. (2007) (0)
[Polyneuropathy is an early finding in primary systemic amyloidosis]. (2000) (0)
Lambert–Eaton Syndrome (2010) (0)
velocity and skin temperature . between nerve conduction The non-linear relationship (0)
[Diagnostic criteria of trigeminal neuralgia-facial pains]. (1973) (0)
[Epileptic hallucinations in 1900--poetry or truth?]. (1987) (0)
[Occupational medicine problems in hospitals]. (1984) (0)
Diseases of the Basal Ganglia (1980) (0)
Evans blue ascounterstain inthedemonstration ofmuscle antibodies byimmunofluorescence inmyasthenia gravis (1973) (0)
IN17-MO-02 Summary of the world federation of neurology (WFN) Africa initiative (2009) (0)
Opening remarks (1995) (0)
Reduced diastolic heart function in patients with myasthenia gravis (1991) (0)
Neuro-Immunological Model Diseases (1980) (0)
[Acute infectious myelitis]. (2001) (0)
[Hypocalcemia and tetany induced by antiepileptic treatment]. (1977) (0)
The World Federation of Neurology: Structure and Organization (2014) (0)
Abstract of the Second European Conference on Myasthenia Gravis held in Tremezzo, Italy on 12–14 June 1989CNS involvement in myasthenia gravis (1989) (0)
Infections of the Central Nervous System (1980) (0)
Polynevropati er et tidlig funn ved primær systemisk amyloidose (2000) (0)
[But Rocambole was not dead]. (1991) (0)
Myasthenia gravis Major problems in neurology, vol. 11γ by R.P. Lisak and R.L. Barchi (Eds.), 244 pages, W.B. Saunders Comp., Philadelphia, PA, London, 1982. US$ 23.00 (1982) (0)
Clinical neurochemistry Vol. 1 and 2, by H.S. Bachelard, G.G. Lunt and C.D. Marsden (Eds.), Academic Press, London, 1986 (1987) (0)
Neurological Manifestations of Systemic Lupus erythematosus and Related Disorders (1980) (0)
Contents Vol. 49, 2003 (2003) (0)
4-34-10 Cell mediated immune response against titin in myasthenia gravis; evidence for the involvement of TH1 cells (1997) (0)
PL04-TU-01 Bringing neurology to the developing world: the time is now (2009) (0)
The World Federation of Neurology Applied Research Committee (2014) (0)
Neurology and public health: strategy and perspectives. (1997) (0)
Når kan diagnosen multippel sklerose stilles (2003) (0)
[Drug therapy in myasthenia gravis]. (1971) (0)
[Painful ophthalmoplegia: the Tolosa-Hunt syndrome]. (1981) (0)
Subject Index Vol. 49, 2003 (2003) (0)
Interaction of Fc gamma in Coombs' test with tanned red cells. (1973) (0)
MYOCARDIAL INVOLVEMENT IN MYASTHENIA GRAVIS (1982) (0)
Myasthenia Gravis Patients have a Cellular Immune Response against Titin (1997) (0)
Abstract of the Second European Conference on Myasthenia Gravis held in Tremezzo, Italy on 12–14 June 1989CNS involvement in myasthenia gravis (1989) (0)
Author response. (2014) (0)
Ig classes and IgG subclasses of non-receptor muscle antibodies in myasthenia gravis: Relationship to thymus pathology (1991) (0)
[Treatment of crises in myasthenia gravis]. (1976) (0)
Specificity ofmuscle antibodies inserafrompatients withmyasthenia gravis andfromimmunized rabbits (1974) (0)
Anti-ryanodine receptor antibodies in thymoma-associated myasthenia gravis (1994) (0)
[Myasthenia gravis. Immunologic aspects]. (1971) (0)
[Immunosuppressive treatment in neurological disorders]. (1973) (0)
[Immunomodulated treatment of neurologic diseases]. (1983) (0)
[Interferon-beta in multiple sclerosis--who is going to be treated?]. (1999) (0)
Fcγ receptors on thymomas from patients with myasthenia gravis (MG) (1987) (0)
[Organic solvents. Damage to the peripheral nervous system]. (1985) (0)
Ryanodine receptorantibodies related toseverity ofthymomaassociated myasthenia gravis (1994) (0)
Titin and ryanodine receptor antibodies and neuromuscular involvement in myasthenia gravis (2008) (0)
Autoimmunity and thymus pathology in myasthenia gravis (1991) (0)
The Shaping of the Organization (2014) (0)
Epidemiological studies on multiple sclerosis (1985) (0)
Communication in the World Federation of Neurology (2014) (0)
[Is thrombolytic therapy effective in stroke?]. (2000) (0)
The International (World) Congresses of Neurology (2014) (0)
[Amyotrophic lateral sclerosis--light at the end of the tunnel?]. (1999) (0)
Myasthenia Gravis (2012) (0)
MYASTHENIA GRAVIS BINDING OF ANTIBODIES TO MUSCLE TISSUE (1970) (0)
Immunoneuropathology (Clinics in Immunology and Allergy, Vol. 2/No. 2), Guest Editor: Byron H. Waksman, 486 pages, W.B. Saunders Comp., Philadelphia, PA, London, 1982, £11.75 (1983) (0)
Contents, Vol. 29, 1989 (1989) (0)
Title Page / Contents / Foreword / Preface (1980) (0)
[abstract] LONG TERM NEUROLOGICAL HEALTH EFFECTS OF DEEP DIVING. (1989) (0)
Subject Index Vol. 29, 1989 (1989) (0)
[Spinal fluid changes in various nervous system diseases. Spinal fluid examination as a routine method]. (1975) (0)
postoperative respiratory complications after thymectomy Preoperative preparation of patients with myasthenia gravis forestalls (2013) (0)
International Newsletter (2011) (0)
[Drug therapy in myasthenia gravis]. (1976) (0)
[Myasthenia gravis--a contraindication for treatment with chlorpromazine]. (1966) (0)
[Drug induced IgA deficiency in epilepsy]. (1976) (0)
Immunological Aspects of Schizophrenia (1980) (0)
Thymectomy for myasthenia gravis. (1972) (0)
Why was the English Malady ‘English’? (2011) (0)
In Service of the World Federation of Neurology (2014) (0)
World Federation of Neurology 1957–2007 (2007) (0)
Acknowledgement to Referees 2005 (2005) (0)
[Medical treatment abroad. Why Bjørnstjerne Bjørnson died in Paris 1910]. (1995) (0)
[Treatment with botulinum toxin--a new and effective therapy]. (1992) (0)
[More stroke units]. (1993) (0)
Regional Neurological Associations (2014) (0)
[The year of the brain 1995]. (1995) (0)
[Myelin antibodies]. (1975) (0)
[When can the diagnosis of multiple sclerosis be confirmed?]. (2003) (0)
Severity of thymoma-associated myasthenia gravis is related to the presence of anti-ryanodine receptor antibodies (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Johan Arild Aarli?

Johan Arild Aarli is affiliated with the following schools:

University of Bergen

Johan Arild Aarli's Academic­Influence.com Rankings

Why Is Johan Arild Aarli Influential?

Johan Arild Aarli's Published Works

Published Works

What Schools Are Affiliated With Johan Arild Aarli?

Johan Arild Aarli's AcademicInfluence.com Rankings